Eric Kozfkay, DO
Pain Medicine · Wyoming, MINPI 1497710610
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (58.4%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. Arthrex accounts for 68.8% of it on its own, with 30 other manufacturers making up the rest. Reporting peaked in 2019 at $14,573 and has fallen 97.5% since, to $357 in 2025. Among pain medicine clinicians in MI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 227 payments — averaging $88.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$14K
- Vertos Medical, Inc.$2K
- Boston Scientific$1K
- Relievant Medsystems, Inc.$375
- Abbott$340
- Nevro Corp.$266
- plus $2K from 25 others
Across 7 payments — averaging $1133.29 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$7K
- Scilex Pharmaceuticals Inc.$500
What the payments were for
- Consulting fees$2,10010%
- Speaking & faculty fees$11,78858%
- Food & beverage$6,29231%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 12 | $13,888 |
| Vertos Medical, Inc. | 31 | $2,038 |
| Boston Scientific | 45 | $1,142 |
| Relievant Medsystems, Inc. | 7 | $375 |
| Abbott | 17 | $340 |
| Nevro Corp. | 10 | $266 |
| Saluda Medical Americas, Inc. | 6 | $261 |
| Pfizer | 12 | $233 |
| Collegium Pharmaceutical, Inc. | 15 | $220 |
| AbbVie(2 entities) | 10 | $210 |
| Teva Pharmaceuticals USA, Inc. | 9 | $158 |
| Novartis | 6 | $127 |
| Amgen | 7 | $125 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $106 |
| GRT US Holding, Inc. | 6 | $103 |
| Medtronic(2 entities) | 6 | $84 |
| Vertiflex, Inc. | 2 | $80 |
| Stryker | 2 | $77 |
| Vertical Pharmaceuticals, LLC | 3 | $49 |
| Biodelivery Sciences International, Inc. | 3 | $44 |
| Assertio Therapeutics, Inc. | 3 | $40 |
| SPR Therapeutics, Inc | 2 | $35 |
| Biohaven Pharmaceuticals, Inc. | 1 | $31 |
| Si-bone, Inc. | 1 | $24 |
| GSK | 1 | $21 |
| Averitas Pharma Inc. | 1 | $20 |
| Lilly USA, LLC | 1 | $19 |
| Fidia Pharma USA Inc. | 1 | $18 |
| Axonics, Inc. | 1 | $17 |
| Radius Health, Inc. | 1 | $16 |
| IBSA Pharma Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BIOLOGICS CONSUMABLES AUTOLOGOUS BLOOD PRODUCTS ANGEL PRP$1,750
- mild Device Kit$1,346
- BIOLOGICS CONSUMABLES AUTOLOGOUS BLOOD PRODUCTS BONE MARROW$350
- BIOLOGICS CONSUMABLES AUTOLOGOUS BLOOD PRODUCTS PLATELET RICH PLASMA$350
- Evoke$125
- WaveWriter Alpha Prime 16$125
- Intracept$120
- GENERAL PAIN MANAGEMENT$118
- WAVEWRITER ALPHA$114
How this compares
$20,180 in reported general payments places this provider in the 90th percentile of 139 pain medicine providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Emgality PenGalcanezumab-Gnlm | 18 | $11,945 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 526 | $7,913 |
| Oxymorphone Hcl ErOxymorphone Hcl | 14 | $7,069 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 292 | $5,193 |
| Buprenorphine | 15 | $4,139 |
| Fentanyl | 32 | $3,374 |
| Gabapentin | 249 | $2,822 |
| Pregabalin | 49 | $2,621 |
| Morphine Sulfate ErMorphine Sulfate | 73 | $2,491 |
| Methadone Hcl | 79 | $1,743 |
| Oxycodone Hcl | 53 | $1,294 |
| Tramadol Hcl | 151 | $945 |
| Metaxalone | 11 | $868 |
| Tramadol Hcl ErTramadol Hcl | 15 | $765 |
| Methocarbamol | 50 | $630 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Wyoming
- Harry SukumaranRochester Hills$304K
- Nasir KhatriFlint$133K
- Yijia ChuGrand Rapids$88K
- Mark MounayerSouthfield$85K
- Jeffrey RosenbergCanton$44K
- Alexander TurfeWyandotte$41K
- Kendall GroseWyandotte$26K
- Craig HartrickRoyal Oak$26K
- Patrick ForrestAnn Arbor$23K
- Anmar DalatiDetroit$23K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.